Back
Ingevity Vs. ResMed Industry Stock Comparison
Sell
27
NGVT
Ingevity
Last Price:
43.68
Seasonality Move:
4.96%
Sell
30
RMD
ResMed
Last Price:
191.79
Seasonality Move:
6.67%
Sell
27
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $43.71. The Score for NGVT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
- The current ResMed [RMD] share price is $191.42. The Score for RMD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NGVT Stock Price Chart
RMD Stock Price Chart
NGVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.47 | Sell |
Relative Strength Index (14 RSI): | 35.4 | Sell |
Chaikin Money Flow: | -160045 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.32 - 48.06) | Sell |
Bollinger Bands (100): | (44.28 - 50.62) | Sell |
RMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.24 | Sell |
Relative Strength Index (14 RSI): | 36.96 | Sell |
Chaikin Money Flow: | -790759 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (195.99 - 215.37) | Sell |
Bollinger Bands (100): | (182.26 - 211.22) | Sell |
NGVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.01 | Sell |
20-day SMA: | 45.77 | Sell |
50-day SMA: | 48.84 | Sell |
200-day SMA: | 45.18 | Sell |
8-day EMA: | 44.31 | Sell |
20-day EMA: | 45.65 | Sell |
50-day EMA: | 47.2 | Sell |
200-day EMA: | 48.5 | Sell |
RMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 195.87 | Sell |
20-day SMA: | 204.74 | Sell |
50-day SMA: | 207.09 | Sell |
200-day SMA: | 177.56 | Buy |
8-day EMA: | 194.67 | Sell |
20-day EMA: | 201.7 | Sell |
50-day EMA: | 203.15 | Sell |
200-day EMA: | 191.93 | Sell |
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.39 per share, an increase this year of $0.05 per share, and an increase next year of $1.18 per share.
ResMed Earnings Growth & RMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.07 per share, an increase this year of $1.20 per share, and an increase next year of $0.90 per share.
Ingevity Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ResMed Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |